Precision BioSciences, Inc. - Common Stock (NQ:DTIL)

6.415 -0.225 (-3.39%)

Delayed Quote Updated: 12:56 PM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Precision BioSciences, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Precision BioSciences (NASDAQ:DTIL) Passes Minervini Trend Template and High-Growth Momentum Screen ↗

August 08, 2026

Via Chartmill

These stocks are gapping in today's session ↗

June 08, 2026

Via Chartmill

Precision BioSciences Inc (NASDAQ:DTIL) Stock Falls After Q3 2025 Earnings and Revenue Miss ↗

November 03, 2025

Precision BioSciences (DTIL) reported a major Q3 2025 earnings and revenue miss, causing shares to fall. Despite the financial setback, the company highlighted progress in its gene editing pipeline.

Via Chartmill

Earnings Scheduled For November 3, 2025 ↗

November 03, 2025

Via Benzinga

DTIL Revenue Drops 99% ↗

August 07, 2025

Via The Motley Fool

Topics Intellectual Property

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Precision Bio's DMD Therapy Gets Rare Pediatric Status, But Stock Slides; Retail Crowd Sees ‘Good Risk-Reward’ ↗

June 25, 2025

The FDA designation could make Precision eligible for a valuable Priority Review Voucher, while preclinical data showed strong dystrophin restoration across key muscle groups.

Via Stocktwits

Deep Dive Into Precision BioSciences Stock: Analyst Perspectives (4 Ratings) ↗

May 16, 2024

Via Benzinga

Earnings Preview: Precision BioSciences ↗

March 26, 2024

Via Benzinga

Discover the top movers in Wednesday's pre-market session. ↗

June 25, 2025

The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 25, 2025

Via Benzinga

Uncovering Potential: Precision BioSciences's Earnings Preview ↗

May 14, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 15, 2025

Via Benzinga

Earnings Scheduled For May 15, 2025 ↗

May 15, 2025

Via Benzinga

Earnings Scheduled For March 26, 2025 ↗

March 26, 2025

Via Benzinga

Assessing Precision BioSciences: Insights From 4 Financial Analysts ↗

March 19, 2025

Via Benzinga

Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket ↗

March 17, 2025

Via Benzinga

Precision BioSciences Touts Encouraging Initial Safety And Antiviral Activity Of Hepatitis B Treatment Candidate ↗

February 19, 2025

Precision BioSciences reports early PBGENE-HBV trial data showing safety and antiviral activity in chronic Hepatitis B patients, with more results expected in 2025.

Via Benzinga

Precision BioSciences' Gene Editing Platform Has Differentiated Mechanism, And Is Potentially Competitive: Analyst ↗

January 10, 2025

Precision BioSciences gains momentum as iECURE reports positive ECUR-506 data, and analysts forecast significant HBV program-driven stock growth.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 10, 2025

Via Benzinga

Why Zoomcar Shares Are Trading Higher By Over 40%; Here Are 20 Stocks Moving Premarket ↗

January 10, 2025

Via Benzinga

7 Biotech Stocks to Buy for Their Game-Changing Potential ↗

August 08, 2024

Although the market may be reeling from the recent fallout, the red ink presents a viable opportunity in these biotech stocks.

Via InvestorPlace

DTIL Stock Earnings: Precision BioSciences Beats EPS, Beats Revenue for Q1 2024 ↗

May 13, 2024

DTIL stock results show that Precision BioSciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 17, 2024

Via Benzinga

DTIL Stock Earnings: Precision BioSciences Misses EPS, Misses Revenue for Q4 2023 ↗

March 27, 2024

DTIL stock results show that Precision BioSciences missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 01, 2024

Via Benzinga

Earnings Scheduled For March 27, 2024 ↗

March 27, 2024

Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million.

Via Benzinga

SPX, Nasdaq Look To Continue Rally ↗

March 01, 2024

Fresh off a fourth-straight monthly win on Wall Street, stocks are on the rise as the week winds down.

Via Talk Markets

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 01, 2024

Via Benzinga

Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 01, 2024

Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results.

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.